+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
RSV Diagnostics Market by Test Type, Product, Technology Platform, End User, Sample Type, Distribution Channel, Age Group - Global Forecast to 2030- Product Image
RSV Diagnostics Market by Test Type, Product, Technology Platform, End User, Sample Type, Distribution Channel, Age Group - Global Forecast to 2030- Product Image
Sale

RSV Diagnostics Market by Test Type, Product, Technology Platform, End User, Sample Type, Distribution Channel, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889855
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RSV Diagnostics Market grew from USD 1.17 billion in 2024 to USD 1.28 billion in 2025. It is expected to continue growing at a CAGR of 9.14%, reaching USD 1.98 billion by 2030.

Navigating the Shifting Current of RSV Diagnostics

Respiratory syncytial virus remains a formidable respiratory pathogen that poses significant threats across age groups, particularly infants and older adults. In recent years, the urgency to refine diagnostic approaches has intensified as healthcare systems seek to accelerate detection and curtail transmission. Diagnostics drive clinical decision-making, guide patient management, and inform public health interventions against seasonal RSV outbreaks. As the convergence of technological innovation and regulatory momentum reshapes the testing environment, stakeholders must grasp evolving market dynamics to navigate potential disruptions with confidence.

This report delivers a clear-eyed analysis of the RSV diagnostics sector, spotlighting critical shifts in testing modalities, supply chain influences, and regional variations. Without dwelling on forecasts or projections, it scrutinizes real-world factors such as tariffs, segmentation drivers, and competitive landscapes to distill actionable insights. Whether you represent a diagnostic developer, laboratory network, or provider organization, this introduction sets the stage for a deeper exploration of the forces redefining RSV testing.

Emerging Disruptors Redefining the RSV Testing Arena

The past few years have seen a seismic shift in how RSV diagnostics are conceived and deployed. Advances in point-of-care molecular platforms have elevated the speed and precision of detection, while next-generation sequencing has opened avenues for strain differentiation and epidemiological surveillance. Integration of microfluidics into rapid testing devices has brought laboratory-grade accuracy closer to patients’ bedsides, ushering in a new era of decentralized testing that leverages automation to reduce human error.

Simultaneously, digital health solutions have woven themselves into the diagnostic workflow. Cloud-based data aggregation, remote reporting applications, and artificial intelligence-driven result interpretation collectively streamline case management and resource allocation. As regulatory bodies adapt to emergent technologies with accelerated pathways, early adopters of these innovations gain a competitive edge. The transformation extends beyond instrumentation, influencing sample collection methods, reagent formulations, and collaborative partnerships between diagnostic providers and technology firms. Understanding these converging trends is fundamental to crafting a resilient strategy in a market marked by rapid evolution.

Assessing the Ripple Effect of 2025 US Tariff Adjustments

In 2025, adjustments to tariff structures in the United States have introduced new cost pressures on imported diagnostic components. Increased duties on laboratory equipment and reagents have raised landed costs for analyzers, PCR machines, buffers, and enzymes, compelling manufacturers to revisit pricing strategies. End users face the prospect of higher per-test expenses, while suppliers must weigh the tradeoff between absorbing duties and passing costs through to customers.

The ripple effect extends through the global supply chain. Distributors are reevaluating sourcing alternatives, exploring near-shoring opportunities to mitigate tariff liabilities. Product roadmaps have been recalibrated, with R&D teams incorporating duty considerations into procurement of critical raw materials. Although agencies continue to grant expedited reviews for novel RSV assays, the interplay between regulatory approvals and tariff constraints demands heightened financial scrutiny. For stakeholders in the United States, the new tariff environment underscores the importance of supply chain diversification and strategic inventory planning to sustain market competitiveness.

Unveiling Critical Market Insights Through Segmentation Prism

A nuanced view of the RSV diagnostics market emerges when segmented by test type, product, technology platform, end user, sample type, distribution channel, and age group. Within test types, immunoassays draw on chemiluminescence immunoassay, enzyme-linked immunosorbent assay, and immunofluorescence assay advances to deliver enhanced sensitivity in centralized labs, whereas molecular tests leverage isothermal amplification, next-generation sequencing, and real-time polymerase chain reaction to accelerate pathogen identification. Rapid tests have evolved beyond simple visual readouts, incorporating lateral flow assay and microfluidic assay techniques to strike a balance between speed and accuracy in decentralized settings.

Focusing on product categories, instruments such as analyzers and PCR machines underpin high-throughput laboratory operations, while kits for saliva and swab collection streamline sample acquisition workflows. Reagents, including specialized buffers and enzymes, remain vital to assay performance and stability. Examining technology platforms, enzyme-linked immunosorbent assay, immunofluorescence, and PCR methods each offer unique value propositions, from high throughput to multiplexing capabilities and deep analytical resolution.

End users span academic institutes pursuing translational research, clinics seeking rapid point-of-care results, diagnostic laboratories optimizing throughput, home care providers focused on patient convenience, and hospital laboratories managing intensive care demands. Sample preferences range from blood draws to nasopharyngeal swabs and saliva specimens, reflecting tradeoffs between invasiveness and diagnostic yield. Distribution channels oscillate between offline networks that leverage established laboratory supply chains and online platforms that enable direct procurement of kits and reagents. Finally, age group considerations guide assay design and regulatory strategy, as adult, geriatric, and pediatric populations present distinct clinical profiles and sampling sensitivities that influence test adoption and performance.

Spotlight on Regional Dynamics Driving RSV Diagnostic Trends

Regional dynamics play a pivotal role in shaping RSV diagnostics adoption and innovation trajectories. In the Americas, robust funding for public health initiatives and established diagnostic infrastructure drive strong uptake of high-sensitivity molecular assays, whereas Latin American markets present pockets of rapid growth as healthcare investments expand. Across Europe, Middle East & Africa, regulatory harmonization efforts and collaborative disease surveillance networks boost demand for multiplex platforms that can simultaneously detect RSV and other respiratory pathogens. Infrastructure disparities in certain EMEA regions underscore the need for scalable, cost-effective point-of-care solutions.

Asia-Pacific exemplifies a diverse tapestry of market maturity. Economies with advanced healthcare systems invest heavily in automated immunoassay and molecular laboratories, while emerging markets prioritize portable rapid tests to enable community-level screening. Regional manufacturing hubs are gaining prominence, lowering lead times and fostering partnerships that accelerate local assay development. Recognizing these regional differentiators is essential for stakeholders aiming to tailor their market entry and go-to-market strategies effectively.

Leading Players Forging the Future of RSV Diagnostics

Key industry participants are actively shaping the RSV diagnostics arena through strategic innovation, capacity expansion, and collaborative ventures. Leading diagnostic developers have invested in proprietary chemistries and advanced instrument platforms to enhance throughput and analytical rigor. Several prominent firms have forged alliances with software providers to integrate diagnostic output into electronic health record systems for seamless data flow and real-time surveillance. Mergers and acquisitions continue to redraw the competitive map, enabling companies with complementary capabilities to broaden their assay portfolios and extend geographic reach.

In parallel, emerging players have introduced specialized rapid test offerings that capitalize on microfluidic technologies and enhanced reagent formulations. Partnerships between reagent producers and instrument manufacturers have shortened validation cycles and accelerated time-to-market for new assays. Through a combination of strategic alliances, targeted R&D, and optimized manufacturing footprints, these companies are positioning themselves at the forefront of next-generation RSV diagnostics.

Strategic Actions to Capitalize on RSV Diagnostic Opportunities

Industry leaders should prioritize modular diagnostic platforms that accommodate both high-throughput laboratory assays and near-patient testing, ensuring flexibility to meet evolving clinical demands. Investment in localized manufacturing capabilities can mitigate exposure to tariff fluctuations and supply chain disruptions while enhancing responsiveness to regional requirements. Strengthening collaborations with digital health providers will unlock advanced analytics, enabling predictive insights and streamlined workflow integration.

Targeted partnerships within academic and clinical research networks can accelerate the validation of novel biomarkers and multiplex assays, driving differentiation in a crowded market. Executives should align product roadmaps with anticipated regulatory shifts, proactively preparing for changes in approval criteria and reimbursement frameworks. Finally, a continuous feedback loop with end users-from home care personnel to hospital laboratory directors-will inform iterative improvements, ensuring that diagnostics not only meet sensitivity and specificity benchmarks but also address practical workflow and usability considerations.

Robust Methodological Framework Underpinning Our Analysis

This analysis is underpinned by a rigorous, dual-phase research design combining comprehensive secondary data review with in-depth primary interviews. The secondary phase entailed a systematic examination of peer-reviewed literature, regulatory filings, company financial disclosures, and industry white papers to chart historical trends and validate technological developments. In the primary phase, structured discussions were conducted with senior leaders across diagnostic development, laboratory management, and public health agencies to capture nuanced perspectives on market drivers and barriers.

Data triangulation methods were applied to reconcile divergent sources, ensuring credibility and consistency in the findings. Qualitative insights from expert dialogues were synthesized alongside quantitative observations from procurement databases and sales reports. Throughout the process, stringent quality controls-such as source attribution, cross-referencing of claims, and iterative peer reviews-were employed to uphold analytical integrity. This robust framework supports the report’s strategic recommendations and ensures that the insights are both actionable and grounded in verifiable evidence.

Conclusive Perspectives on the Evolving RSV Diagnostic Ecosystem

As the RSV diagnostics landscape continues to evolve, stakeholders face a complex interplay of technological innovation, regulatory change, and cost considerations. From the maturation of microfluidic rapid tests to the expansion of next-generation sequencing for strain surveillance, the sector offers myriad pathways for differentiation and growth. Regional nuances further underscore the importance of tailored approaches, while tariff adjustments highlight the need for resilient supply chains.

Success in this dynamic environment demands a clear understanding of segment-specific drivers, strategic flexibility in product development, and proactive engagement with evolving policy frameworks. By synthesizing segmentation insights, regional analysis, and competitive intelligence, decision-makers can chart a course that maximizes value and supports improved patient outcomes. This report provides the foundational knowledge required to navigate these complexities and harness emerging opportunities in RSV diagnostics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Test Type
    • Immunoassay
      • Chemiluminescence Immunoassay
      • Enzyme Linked Immunosorbent Assay
      • Immunofluorescence Assay
    • Molecular Test
      • Isothermal Amplification
      • Next Generation Sequencing
      • Real Time Polymerase Chain Reaction
    • Rapid Test
      • Lateral Flow Assay
      • Microfluidic Assay
  • Product
    • Instruments
      • Analyzers
      • PCR Machines
    • Kits
      • Saliva Collection Kits
      • Swab Collection Kits
    • Reagents
      • Buffers
      • Enzymes
  • Technology Platform
    • ELISA
    • Immunofluorescence
    • PCR
  • End User
    • Academic Institutes
    • Clinics
    • Diagnostic Laboratories
    • Home Care
    • Hospital Laboratories
  • Sample Type
    • Blood
    • Nasopharyngeal Swab
    • Saliva
  • Distribution Channel
    • Offline
    • Online
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Meridian Bioscience, Inc.
  • DiaSorin S.p.A.
  • QIAGEN N.V.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. RSV Diagnostics Market, by Test Type
8.1. Introduction
8.2. Immunoassay
8.2.1. Chemiluminescence Immunoassay
8.2.2. Enzyme Linked Immunosorbent Assay
8.2.3. Immunofluorescence Assay
8.3. Molecular Test
8.3.1. Isothermal Amplification
8.3.2. Next Generation Sequencing
8.3.3. Real Time Polymerase Chain Reaction
8.4. Rapid Test
8.4.1. Lateral Flow Assay
8.4.2. Microfluidic Assay
9. RSV Diagnostics Market, by Product
9.1. Introduction
9.2. Instruments
9.2.1. Analyzers
9.2.2. PCR Machines
9.3. Kits
9.3.1. Saliva Collection Kits
9.3.2. Swab Collection Kits
9.4. Reagents
9.4.1. Buffers
9.4.2. Enzymes
10. RSV Diagnostics Market, by Technology Platform
10.1. Introduction
10.2. ELISA
10.3. Immunofluorescence
10.4. PCR
11. RSV Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Home Care
11.6. Hospital Laboratories
12. RSV Diagnostics Market, by Sample Type
12.1. Introduction
12.2. Blood
12.3. Nasopharyngeal Swab
12.4. Saliva
13. RSV Diagnostics Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. RSV Diagnostics Market, by Age Group
14.1. Introduction
14.2. Adult
14.3. Geriatric
14.4. Pediatric
15. Americas RSV Diagnostics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa RSV Diagnostics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific RSV Diagnostics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Roche Diagnostics International AG
18.3.3. QuidelOrtho Corporation
18.3.4. Thermo Fisher Scientific Inc.
18.3.5. bioMérieux SA
18.3.6. Becton, Dickinson and Company
18.3.7. Danaher Corporation
18.3.8. Meridian Bioscience, Inc.
18.3.9. DiaSorin S.p.A.
18.3.10. QIAGEN N.V.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. RSV DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. RSV DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. RSV DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RSV DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY MICROFLUIDIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PCR MACHINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SALIVA COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SWAB COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. CANADA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. CANADA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 85. CANADA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 86. CANADA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 87. CANADA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. CANADA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 89. CANADA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 90. CANADA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 91. CANADA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 92. CANADA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. CANADA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CANADA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 98. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 99. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 100. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 105. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 164. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 165. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 166. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 168. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 171. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 175. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 178. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 179. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 181. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 184. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. ITALY RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. ITALY RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 203. ITALY RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 204. ITALY RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 205. ITALY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. ITALY RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 207. ITALY RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 208. ITALY RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. ITALY RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 210. ITALY RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. ITALY RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 212. ITALY RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. ITALY RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 216. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 217. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 218. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 223. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 225. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 267. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 268. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 269. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 270. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 272. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 275. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. QATAR RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 294. QATAR RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 295. QATAR RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 296. QATAR RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. QATAR RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 298. QATAR RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 299. QATAR RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 300. QATAR RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 301. QATAR RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. QATAR RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 303. QATAR RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. QATAR RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 305. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 306. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 307. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 308. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 309. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 311. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 312. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 313. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 314. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 316. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 318. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 326. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 327. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 329. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 339. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 340. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 342. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 343. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 344. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 345. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 346. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 347. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 348. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 349. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 350. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
TABLE 351. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 352. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 353. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 355. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 356. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 357. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 358. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 359. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR TEST, 2018-2030 (USD MILLION)
TABLE 360. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD MILLION)
TABLE 361. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 362. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 363. TURKEY RSV DIAGNOSTICS MA

Companies Mentioned

The companies profiled in this RSV Diagnostics market report include:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • QuidelOrtho Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Meridian Bioscience, Inc.
  • DiaSorin S.p.A.
  • QIAGEN N.V.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.98 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Respiratory Syncytial Virus Diagnostics - Global Strategic Business Report - Product Image

Respiratory Syncytial Virus Diagnostics - Global Strategic Business Report

  • Report
  • 67 Pages
  • Global
From
RSV Diagnostics - Global Strategic Business Report - Product Image

RSV Diagnostics - Global Strategic Business Report

  • Report
  • 233 Pages
  • Global
From
Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025 - Product Image

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Respiratory Syncytial Virus Diagnostics Market Report by Product Method, End Use, and Region 2024-2032 - Product Image

Respiratory Syncytial Virus Diagnostics Market Report by Product Method, End Use, and Region 2024-2032

  • Report
  • 135 Pages
  • Global
From

About the Respiratory Syncytial Virus Test Market

The Respiratory Syncytial Virus (RSV) Test is a type of infectious disease test used to detect the presence of the RSV virus in a patient's respiratory system. It is typically used to diagnose RSV infection in infants and young children, as well as in adults with weakened immune systems. The test is usually performed by collecting a sample of mucus from the nose or throat and then testing it for the presence of the virus. Results are usually available within a few days. The RSV Test market is a growing segment of the infectious disease testing industry, as the virus is highly contagious and can cause severe respiratory illness in infants and young children. The test is also used to monitor the effectiveness of treatments for RSV infection. Some companies in the RSV Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Quidel. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.